Introduction and aims Ageing impairs the regenerative capacity of the dental pulp-periodontal complex, yet efficient in vivo oral ageing models remain limited. This study evaluated a doxorubicin (DOX)-induced premature senescence model in the murine dental pulp-periodontal complex and explored the mechanisms associated with tissue degeneration. Methods Young C57BL/6J mice received DOX via 2 intraperitoneal (i.p.) injections (cumulative doses: 5, 10, or 20 mg/kg) and were compared with naturally aged mice (12 and 18 months). Systemic tolerance and premature senescence phenotypes were assessed using micro-computed tomography, histopathology, and immunostaining for senescence markers (p16, p21) and senescence-associated secretory phenotype (SASP) factors. Further molecular characterisation was conducted in vitro on DOX-treated primary human dental pulp cells via SA-β-gal staining, RNA sequencing, and RT-qPCR. Results The 10 mg/kg DOX regimen induced multiple features associated with therapy-induced premature senescence, including significant alveolar bone loss and osteoclast activation. In DOX-treated pulps, cellularity and vascularity were reduced alongside p16/p21 accumulation and elevated SASP factors (IL-6, IL-1β), characterised by distinct matrix degradation rather than typical fibrosis. Transcriptomic analysis revealed a p53-associated premature senescence signature. Furthermore, DOX upregulated the Wnt antagonist DKK1 and downregulated the osteogenic factor SP7, suggesting Wnt signalling suppression is closely linked to an altered odontogenesis-associated molecular profile. Conclusion DOX induces multiple senescence-associated and degenerative changes in the murine dental pulp-periodontal complex. This model provides a valuable preclinical platform for studying stress-induced oral tissue degeneration and evaluating therapeutic interventions. Clinical Relevance Age-related tissue destruction in the dental pulp and periodontium compromises tooth survival, yet mechanistic understanding and targeted models are lacking. Characterised by p53/p21-associated stress responses and DKK1-related expression changes, the DOX model provides an experimental platform for investigating therapy-associated premature senescence in the oral cavity, facilitating the evaluation of hypotheses and candidate interventions.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: